Earnings (Loss) Per Share - Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014		Jun. 30, 2015	Jun. 30, 2014
Earnings Per Share [Abstract]
Loss from continuing operations	$ (1,193)	$ (417)	[1]	$ (3,484)	$ (1,148)	[2]
Loss per common share from continuing operations	$ (3.05)	$ (1.06)		$ (8.91)	$ (2.90)
Income (loss) from discontinued operations	$ (23)	$ 122		$ (137)	$ 55
Income (loss) per common share from discontinued operations	$ (.06)	$ .31		$ (.35)	$ .14
Net loss attributed to common stock	$ (1,216)	$ (295)		$ (3,621)	$ (1,093)
Weighted average shares outstanding - basic	391,000	393,000		391,000	396,000
Net loss per common share - basic	$ (3.11)	$ (.75)		$ (9.26)	$ (2.76)
Preferred stock
Diluted loss	$ (1,216)	$ (295)		$ (3,621)	$ (1,093)
Weighted average shares outstanding - diluted	391,000	393,000		391,000	396,000
Diluted loss per share	$ (3.11)	$ (.75)		$ (9.26)	$ (2.76)

[1] Includes accrual of dividends, net of the gain on dividends paid with common shares, related to preferred stock of $4 thousand for the three months ended June 30, 2014.

[2] Includes accrual of dividends, net of the gain on dividends paid with common shares, related to preferred stock for the six months ended June 30, 2014.

[3] Includes 11 shares of our common stock related to our Series G1 and Series G2 preferred stock for the three months ended June 30, 2014. These shares were issuable upon their conversion in the period presented and were excluded from the calculation of diluted earnings per share as their effect would have been antidilutive. In December 2014, we repurchased all outstanding shares of our Series G1 and Series G2 preferred stock. As a result, there is no dilutive effect for the three months ended June 30, 2015.

[4] Includes 23 shares of our common stock related to our Series G1 and Series G2 preferred stock for the six months ended June 30, 2014. These shares were issuable upon their conversion in the period presented and were excluded from the calculation of diluted earnings per share as their effect would have been antidilutive. In December 2014, we repurchased all outstanding shares of our Series G1 and Series G2 preferred stock. As a result, there is no dilutive effect for the six months ended June 30, 2015.